Sunshine Biopharma, Inc. (SBFM)
0.243
+0.01
(+2.84%)
USD |
NASDAQ |
Oct 14, 16:00
0.2292
-0.01
(-5.68%)
After-Hours: 20:00
Sunshine Biopharma Price to Book Value : 0.0211 for Oct. 14, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 0.0211 |
| October 13, 2026 | 0.0205 |
| October 12, 2026 | 0.0262 |
| October 09, 2026 | 0.0293 |
| October 08, 2026 | 0.0373 |
| October 07, 2026 | 0.0607 |
| October 06, 2026 | 0.0345 |
| October 05, 2026 | 0.0365 |
| October 02, 2026 | 0.0578 |
| October 01, 2026 | 0.0597 |
| September 30, 2026 | 0.0671 |
| September 29, 2026 | 0.0683 |
| September 28, 2026 | 0.071 |
| September 25, 2026 | 0.0731 |
| September 24, 2026 | 0.0694 |
| September 23, 2026 | 0.076 |
| September 22, 2026 | 0.0786 |
| September 21, 2026 | 0.0789 |
| September 18, 2026 | 0.0781 |
| September 17, 2026 | 0.073 |
| September 16, 2026 | 0.0894 |
| September 15, 2026 | 0.0894 |
| September 14, 2026 | 0.0928 |
| September 11, 2026 | 0.092 |
| September 10, 2026 | 0.0937 |
| Date | Value |
|---|---|
| September 09, 2026 | 0.0972 |
| September 08, 2026 | 0.0998 |
| September 04, 2026 | 0.0989 |
| September 03, 2026 | 0.0963 |
| September 02, 2026 | 0.1015 |
| September 01, 2026 | 0.0981 |
| August 31, 2026 | 0.0972 |
| August 28, 2026 | 0.0998 |
| August 27, 2026 | 0.1102 |
| August 26, 2026 | 0.1076 |
| August 25, 2026 | 0.0989 |
| August 24, 2026 | 0.1007 |
| August 21, 2026 | 0.1007 |
| August 20, 2026 | 0.1007 |
| August 19, 2026 | 0.1015 |
| August 18, 2026 | 0.0972 |
| August 17, 2026 | 0.0972 |
| August 14, 2026 | 0.0998 |
| August 13, 2026 | 0.1041 |
| August 12, 2026 | 0.105 |
| August 11, 2026 | 0.1067 |
| August 10, 2026 | 0.1059 |
| August 07, 2026 | 0.1067 |
| August 06, 2026 | 0.1215 |
| August 05, 2026 | 0.1154 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.536 |
| Alnylam Pharmaceuticals, Inc. | 22.17 |
| Anika Therapeutics, Inc. | 1.974 |
| Savara, Inc. | 6.806 |
| Vericel Corp. | 5.566 |
Price to Book Value Related Metrics
| PS Ratio | 0.0048 |
| Price | 0.243 |
| Earnings Yield | -4.21K% |
| Market Cap | 0.5804M |